This bibliography shows the most interesting papers selected from pmc PubMedCentral which were newly included in covid021i
It is available online and for download at http://www.kidney.de/write/PMCmedVIP_covid021i.html
Skewed: Nephrology, Rheumatology, Immunology, Cell Biology, Research Methods. on-topic and educational Clinical Medicine.
The full table of all monthly collections is: at house-of-papers.com
PMC searches were done at moremed.org





{{tp|p=33205948|t=2020. Detection, Mapping, and Proteotyping of SARS-CoV-2 Coronavirus with High Resolution Mass Spectrometry.|pdf=|usr=}}
{{tp|p=33186121|t=2020. Comparative analysis of SARS-CoV-2 and its receptor ACE2 with evolutionarily related coronaviruses.|pdf=|usr=}}
{{tp|p=33231569|t=2020. Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer.|pdf=|usr=}}
{{tp|p=33203793|t=2020. Cell differentiation and aging accompanied by depletion of the ACE2 protein.|pdf=|usr=}}
{{tp|p=33237794|t=2020. Immunoglobulin Deficiency as an Indicator of Disease Severity in Patients with COVID-19.|pdf=|usr=}}
{{tp|p=33082620|t=2020. Insights into the Immunopathophysiology of Severe COVID-19 in Metabolic Disorders.|pdf=|usr=}}
{{tp|p=33183023|t=2020. Morphological changes of lymphocytes in peripheral blood smears of patients with COVID-19.|pdf=|usr=}}
{{tp|p=33240994|t=2020. Dynamic changes of T-lymphocyte subsets and the correlations with 89 patients with coronavirus disease 2019 (COVID-19).|pdf=|usr=}}
{{tp|p=33145296|t=2020. Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study.|pdf=|usr=}}
{{tp|p=33231054|t=2020. Recomendaciones para el manejo inicial del sindrome inflamatorio multisistemico relacionado temporalmente con COVID-19, en ninos y adolescentes.|pdf=|usr=}}
{{tp|p=33201341|t=2020. ceRNA analysis of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33190827|t=2020. T cell immunity to SARS-CoV-2 following natural infection and vaccination.|pdf=|usr=}}
{{tp|p=33220925|t=2020. T-cell dysregulation in COVID-19.|pdf=|usr=}}
{{tp|p=33187644|t=2020. Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity.|pdf=|usr=}}
{{tp|p=33234239|t=2020. Host-directed editing of the SARS-CoV-2 genome.|pdf=|usr=}}
{{tp|p=33199022|t=2020. The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design.|pdf=|usr=}}
{{tp|p=33220921|t=2020. Functional importance of the D614G mutation in the SARS-CoV-2 spike protein.|pdf=|usr=}}
{{tp|p=33027600|t=2020. A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis.|pdf=|usr=}}
{{tp|p=33189832|t=2020. The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response.|pdf=|usr=}}
{{tp|p=33066821|t=2020. COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein.|pdf=|usr=}}
{{tp|p=33224987|t=2020. Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation.|pdf=|usr=}}
{{tp|p=33225414|t=2020. (1)H,(13)C and (15)N chemical shift assignments of the SUD domains of SARS-CoV-2 non-structural protein 3c: "the N-terminal domain-SUD-N".|pdf=|usr=}}
{{tp|p=33219414|t=2020. (1)H, (13)C, and (15)N backbone and side chain chemical shift assignments of the SARS-CoV-2 non-structural protein 7.|pdf=|usr=}}
{{tp|p=33191083|t=2020. Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors.|pdf=|usr=}}
{{tp|p=33253634|t=2020. A Multiscale Coarse-grained Model of the SARS-CoV-2 Virion.|pdf=|usr=}}
{{tp|p=33189680|t=2020. The Flexibility of ACE2 in the Context of SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=33152090|t=2020. COVID-19-induced atypical pulmonary lymphocytes.|pdf=|usr=}}
{{tp|p=33119481|t=2020. Kawasaki-like disease and acute myocarditis in the SARS-CoV-2 pandemic - reports of three adolescents.|pdf=|usr=}}
{{tp|p=33097885|t=2020. Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33188677|t=2020. Numbers and phenotype of non-classical CD14dimCD16+ monocytes are predictors of adverse clinical outcome in patients with coronary artery disease and severe SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=33207184|t=2020. Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality.|pdf=|usr=}}
{{tp|p=33232691|t=2020. Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis.|pdf=|usr=}}
{{tp|p=33245857|t=2020. Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies.|pdf=|usr=}}
{{tp|p=33242391|t=2020. Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles.|pdf=|usr=}}
{{tp|p=33207245|t=2020. SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in beta Cells.|pdf=|usr=}}
{{tp|p=33207244|t=2020. Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19.|pdf=|usr=}}
{{tp|p=33220791|t=2020. The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein.|pdf=|usr=}}
{{tp|p=33232663|t=2020. Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men.|pdf=|usr=}}
{{tp|p=33196989|t=2020. Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention.|pdf=|usr=}}
{{tp|p=33238570|t=2020. The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes.|pdf=|usr=}}
{{tp|p=33217417|t=2020. Lower respiratory tract myeloid cells harbor SARS-CoV-2 and display an inflammatory phenotype.|pdf=|usr=}}
{{tp|p=33203513|t=2020. An enlightening role for cytokine storm in coronavirus infection.|pdf=|usr=}}
{{tp|p=33253854|t=2020. Peripheral immunological features of COVID-19 patients in Taizhou, China: A retrospective study.|pdf=|usr=}}
{{tp|p=33189887|t=2020. Major reduction of NKT cells in patients with severe COVID-19 pneumonia.|pdf=|usr=}}
{{tp|p=32496544|t=2020. Evaluating Immune Dysregulation in Patients With COVID-19 Requires a More Accurate Definition of the CD45RA+ T-cell Phenotype.|pdf=|usr=}}
{{tp|p=33217259|t=2020. Case Report: Pediatric Patient with COVID-19 and Multisystem Inflammatory Syndrome in Children.|pdf=|usr=}}
{{tp|p=33209300|t=2020. Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19.|pdf=|usr=}}
{{tp|p=33162723|t=2020. Stability Analysis in COVID-19 Within-Host Model with Immune Response.|pdf=|usr=}}
{{tp|p=33221119|t=2020. Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism.|pdf=|usr=}}
{{tp|p=33200028|t=2020. Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization.|pdf=|usr=}}
{{tp|p=33217169|t=2020. A Prototype QSP Model of the Immune Response to SARS-CoV-2 for Community Development.|pdf=|usr=}}
{{tp|p=33240687|t=2020. Multisystem Inflammatory Syndrome in Children, the Real Disease of COVID-19 in Pediatrics - A Multicenter Case Series From Al-Ahsa, Saudi Arabia.|pdf=|usr=}}
{{tp|p=33214962|t=2020. Kawasaki Disease-Like Features in 10 Pediatric COVID-19 Cases: A Retrospective Study.|pdf=|usr=}}
{{tp|p=33194461|t=2020. A Rare Presentation of Multi-System Inflammatory Disease in Children Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).|pdf=|usr=}}
{{tp|p=33242255|t=2020. An integrative analysis identifying transcriptional features and key genes involved in COVID-19.|pdf=|usr=}}
{{tp|p=33253796|t=2020. The potential involvement of JAK-STAT signaling pathway in the COVID-19 infection assisted by ACE2.|pdf=|usr=}}
{{tp|p=33220345|t=2020. Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19.|pdf=|usr=}}
{{tp|p=33207533|t=2020. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.|pdf=|usr=}}
{{tp|p=33237152|t=2020. Molecular mechanisms and pharmacological interventions in the replication cycle of human coronaviruses.|pdf=|usr=}}
{{tp|p=33239605|t=2020. Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the 'Common Cold'.|pdf=|usr=}}
{{tp|p=33203641|t=2020. COVID-19 cytokine storm: what is in a name?|pdf=|usr=}}
{{tp|p=33232209|t=2020. Megakaryocytes: Masters of Innate Immunity?|pdf=|usr=}}
{{tp|p=33199021|t=2020. Evolution patterns of SARS-CoV-2: Snapshot on its genome variants.|pdf=|usr=}}
{{tp|p=33249673|t=2020. Specialized proresolving mediators in infection and lung injury.|pdf=|usr=}}
{{tp|p=33244583|t=2020. Novel SARS-CoV-2 encoded small RNAs in the passage to humans.|pdf=|usr=}}
{{tp|p=33205194|t=2020. The SARS-CoV-2 receptor, Angiotensin converting enzyme 2 (ACE2) is required for human endometrial stromal cell decidualization.|pdf=|usr=}}
{{tp|p=33248129|t=2020. From Examining the Relationship between (Corona)Viral Adhesins and Galectins to Glyco-Perspectives.|pdf=|usr=}}
{{tp|p=33243116|t=2020. Can Host Cell Proteins Like ACE2, ADAM17, TMPRSS2, Androgen Receptor be the Efficient Targets in SARS-CoV-2 Infection?|pdf=|usr=}}
{{tp|p=33186231|t=2021. Structural basis of severe acute respiratory syndrome coronavirus 2 infection.|pdf=|usr=}}
{{tp|p=33186230|t=2021. Molecular epidemiology in the HIV and SARS-CoV-2 pandemics.|pdf=|usr=}}
{{tp|p=33200826|t=2020. SARS-CoV-2 nucleocapsid protein phase-separates with RNA and with human hnRNPs.|pdf=|usr=}}
{{tp|p=33202024|t=2020. Metabolic Syndrome and COVID-19: Endocrine-Immune Vascular Interactions Shape the Clinical Course.|pdf=|usr=}}
{{tp|p=33251605|t=2020. Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID-19 patients.|pdf=|usr=}}
{{tp|p=33182073|t=2020. Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics.|pdf=|usr=}}
{{tp|p=33246355|t=2020. A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression.|pdf=|usr=}}
{{tp|p=33234246|t=2020. TAM receptors: A phosphatidylserine receptor family and its implications in viral infections.|pdf=|usr=}}
{{tp|p=33111578|t=2020. Pathogenesis guided therapeutic management of COVID-19: an immunological perspective.|pdf=|usr=}}
{{tp|p=33155525|t=2020. How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?|pdf=|usr=}}
{{tp|p=33191813|t=2020. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.|pdf=|usr=}}
{{tp|p=33215821|t=2020. COVID-19: where have the lymphocytes gone?|pdf=|usr=}}
{{tp|p=33254234|t=2020. Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control.|pdf=|usr=}}
{{tp|p=33247640|t=2020. Post COVID Inflammation Syndrome: Different Manifestations Caused by the Virus.|pdf=|usr=}}
{{tp|p=33249452|t=2020. New Horizons: Does Mineralocorticoid Receptor activation by cortisol cause ATP release and COVID-19 complications?|pdf=|usr=}}
{{tp|p=33184940|t=2020. Clinical significance of the serum IgM and IgG to SARS-CoV-2 in coronavirus disease-2019.|pdf=|usr=}}
{{tp|p=33208459|t=2020. Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile.|pdf=|usr=}}
{{tp|p=33208457|t=2020. SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals.|pdf=|usr=}}
{{tp|p=33249471|t=2020. Serum protein profiling reveals a specific upregulation of the immunomodulatory protein progranulin in COVID-19.|pdf=|usr=}}
{{tp|p=33206973|t=2020. Monocyte CD169 expression as a biomarker in the early diagnosis of COVID-19.|pdf=|usr=}}
{{tp|p=33197260|t=2020. Early plasma IL-37 responses accompanied with low inflammatory cytokines correlate with benign clinical outcomes during SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=33211354|t=2020. Atypical monocytes in COVID-19: Lighting the fire of cytokine storm?|pdf=|usr=}}
{{tp|p=33252101|t=2020. Multisystem inflammatory syndrome in children and SARS-CoV-2: A scoping review.|pdf=|usr=}}
{{tp|p=33188394|t=2020. SARS-CoV-2 triggering severe ARDS and secondary HLH in a 3-year-old child with Down syndrome.|pdf=|usr=}}
{{tp|p=33234675|t=2020. Structure of nonstructural protein 1 from SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33237291|t=2020. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.|pdf=|usr=}}
{{tp|p=33211045|t=2020. A digital protein microarray for COVID-19 cytokine storm monitoring.|pdf=|usr=}}
{{tp|p=33220726|t=2020. Kinetics and seroprevalence of SARS-CoV-2 antibodies in children.|pdf=|usr=}}
{{tp|p=33245861|t=2020. Herd immunity for COVID-19.|pdf=|usr=}}
{{tp|p=33185926|t=2020. SARS-CoV-2-mediated immune system activation and potential application in immunotherapy.|pdf=|usr=}}
{{tp|p=33242097|t=2020. Multisystem Inflammatory Syndrome in Children during the COVID-19 Pandemic: A Case Report on Managing the Hyperinflammation.|pdf=|usr=}}
{{tp|p=33188728|t=2020. Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA.|pdf=|usr=}}
{{tp|p=33244183|t=2020. Deciphering the ins and outs of SARS-CoV-2-specific T cells.|pdf=|usr=}}
{{tp|p=33208929|t=2020. Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19.|pdf=|usr=}}
{{tp|p=33184509|t=2020. Characterization of pre-existing and induced SARS-CoV-2-specific CD8(+) T cells.|pdf=|usr=}}
{{tp|p=33244168|t=2020. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry.|pdf=|usr=}}
{{tp|p=33199863|t=2020. Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals.|pdf=|usr=}}
{{tp|p=33253058|t=2020. A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions.|pdf=|usr=}}
{{tp|p=33236427|t=2020. Immunological basis of virus-host interaction in COVID-19.|pdf=|usr=}}
{{tp|p=33222290|t=2020. Perineal desquamation: An early sign of the Kawasaki disease phenotype of MIS-C.|pdf=|usr=}}
{{tp|p=33249696|t=2020. Kawasaki disease mimickers.|pdf=|usr=}}
{{tp|p=33184170|t=2020. MIS-C and Cardiac Conduction Abnormalities.|pdf=|usr=}}
{{tp|p=33239446|t=2020. Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion.|pdf=|usr=}}
{{tp|p=33203681|t=2020. Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes.|pdf=|usr=}}

{{tp|p=33048448|t=2020. Generation of Recombinant SARS-CoV-2 Using a Bacterial Artificial Chromosome.|pdf=|usr=}}
{{tp|p=33246770|t=2020. An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis.|pdf=|usr=}}
{{tp|p=33199178|t=2020. A clinical trial of IL-15 and IL-21 combination therapy for COVID-19 is warranted.|pdf=|usr=}}
{{tp|p=33186810|t=2020. A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways.|pdf=|usr=}}
{{tp|p=33231169|t=2020. COVID-19 research risks ignoring important host genes due to pre-established research patterns.|pdf=|usr=}}
{{tp|p=33205709|t=2020. Loss of orf3b in the circulating SARS-CoV-2 strains.|pdf=|usr=}}
{{tp|p=33179566|t=2020. Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target.|pdf=|usr=}}
{{tp|p=33131453|t=2020. Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal.|pdf=|usr=}}
{{tp|p=33118859|t=2020. A SARS-CoV-2 variant with the 12-bp deletion at E gene.|pdf=|usr=}}
{{tp|p=33245471|t=2020. Expression and co-expression analyses of TMPRSS2, a key element in COVID-19.|pdf=|usr=}}
{{tp|p=33250893|t=2020. Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains.|pdf=|usr=}}
{{tp|p=33042918|t=2020. Pediatric Inflammatory Multisystem Syndrome Temporally Related With SARS-CoV-2: Immunological Similarities With Acute Rheumatic Fever and Toxic Shock Syndrome.|pdf=|usr=}}
{{tp|p=33251267|t=2020. A Mini-Review on Cell Cycle Regulation of Coronavirus Infection.|pdf=|usr=}}
{{tp|p=33224264|t=2020. Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=33244382|t=2020. Significant changes of CD4, FOXP3, CD25, and IL6 expression level in Iranian COVID-19 patients.|pdf=|usr=}}
{{tp|p=33244381|t=2020. Investigating the human protein-host protein interactome of SARS-CoV-2 infection in the small intestine.|pdf=|usr=}}
{{tp|p=33244380|t=2020. Introducing APOA1 as a key protein in COVID-19 infection: a bioinformatics approach.|pdf=|usr=}}
{{tp|p=33242394|t=2020. Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity.|pdf=|usr=}}
{{tp|p=33232865|t=2020. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.|pdf=|usr=}}
{{tp|p=33239109|t=2020. Increased circulating level of interleukin-6 and CD8(+) T cell exhaustion are associated with progression of COVID-19.|pdf=|usr=}}
{{tp|p=33249264|t=2020. Coevolutionary forces shaping the fitness of SARS-CoV-2 spike glycoprotein against human receptor ACE2.|pdf=|usr=}}
{{tp|p=33206207|t=2020. Histamine receptors and COVID-19.|pdf=|usr=}}
{{tp|p=33072849|t=2020. Understand variability of COVID-19 through population and tissue variations in expression of SARS-CoV-2 host genes.|pdf=|usr=}}
{{tp|p=33221169|t=2020. The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.|pdf=|usr=}}
{{tp|p=33227512|t=2020. Low dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19.|pdf=|usr=}}
{{tp|p=33202218|t=2020. Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated with COVID-19: a meta-analysis and insights into pathogenesis.|pdf=|usr=}}
{{tp|p=33207699|t=2020. Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33043312|t=2020. Synthea Novel coronavirus (COVID-19) model and synthetic data set.|pdf=|usr=}}
{{tp|p=33251489|t=2020. SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain.|pdf=|usr=}}
{{tp|p=33236586|t=2020. Ferritin and Severe COVID-19, from Clinical Observations to Pathogenic Implications and Therapeutic Perspectives.|pdf=|usr=}}
{{tp|p=33236584|t=2020. The Hyper-Inflammatory Response in Adults with Severe COVID-19 Pneumonia Differs from the Cytokine Storm of Hemophagocytic Syndrome.|pdf=|usr=}}
{{tp|p=33221383|t=2020. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19.|pdf=|usr=}}
{{tp|p=33229438|t=2020. The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing assembly of virus-like particles.|pdf=|usr=}}
{{tp|p=33214224|t=2020. SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles.|pdf=|usr=}}
{{tp|p=33243941|t=2020. Characteristics of viral specimens collected from asymptomatic and fatal cases of COVID-19.|pdf=|usr=}}
{{tp|p=33245474|t=2020. N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects.|pdf=|usr=}}
{{tp|p=33216734|t=2020. Does common cold coronavirus infection protect against severe SARS-CoV2 disease?|pdf=|usr=}}
{{tp|p=33233425|t=2020. ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors.|pdf=|usr=}}
{{tp|p=33231615|t=2021. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.|pdf=|usr=}}
{{tp|p=33242672|t=2020. Cytokine storm of a different flavor: the different cytokine signature of SARS-CoV2 the cause of COVID-19 from the original SARS outbreak.|pdf=|usr=}}
{{tp|p=33238745|t=2020. A 23-Year-Old Man With Multisystem Inflammatory Syndrome After Mild COVID-19.|pdf=|usr=}}
{{tp|p=33245961|t=2020. Structural insights into SARS-CoV-2 proteins.|pdf=|usr=}}
{{tp|p=33250660|t=2020. Thermal and hydrodynamic properties of coronavirus at various temperature and pressure via molecular dynamics approach.|pdf=|usr=}}
{{tp|p=33252688|t=2020. Race/Ethnicity Among Children With COVID-19-Associated Multisystem Inflammatory Syndrome.|pdf=|usr=}}
{{tp|p=33220289|t=2020. High GRP78 levels in Covid-19 infection: A case-control study.|pdf=|usr=}}
{{tp|p=33246692|t=2020. More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival.|pdf=|usr=}}
{{tp|p=33231720|t=2020. Lungenveranderungen bei COVID-19 - Storung des pulmonalen Surfactants? : Eine nicht ganz weit hergeholte Hypothese.|pdf=|usr=}}
{{tp|p=33242646|t=2020. Structural and functional insights into non-structural proteins of coronaviruses.|pdf=|usr=}}
{{tp|p=33237893|t=2020. Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network - 12 States, April-August 2020.|pdf=|usr=}}
{{tp|p=33248025|t=2020. Phosphoregulation of Phase Separation by the SARS-CoV-2 N Protein Suggests a Biophysical Basis for its Dual Functions.|pdf=|usr=}}
{{tp|p=33242581|t=2020. The phylogenetic relationship within SARS-CoV-2s: an expanding basal clade.|pdf=|usr=}}
{{tp|p=33200082|t=2020. Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection.|pdf=|usr=}}
{{tp|p=33239366|t=2020. Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets.|pdf=|usr=}}
{{tp|p=33247152|t=2020. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.|pdf=|usr=}}
{{tp|p=33247108|t=2020. Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates.|pdf=|usr=}}
{{tp|p=33243994|t=2020. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.|pdf=|usr=}}
{{tp|p=33239633|t=2020. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33208793|t=2020. SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography.|pdf=|usr=}}
{{tp|p=33208736|t=2020. Architecture of a SARS-CoV-2 mini replication and transcription complex.|pdf=|usr=}}
{{tp|p=33208735|t=2020. Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site.|pdf=|usr=}}
{{tp|p=33203890|t=2020. Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses.|pdf=|usr=}}
{{tp|p=33203833|t=2020. Immune suppression in the early stage of COVID-19 disease.|pdf=|usr=}}
{{tp|p=33160723|t=2020. Sustancia P, citocinas proinflamatorias, receptor de potencial transitorio vaniloide tipo 1 y COVID-19: una hipotesis de trabajo.|pdf=|usr=}}
{{tp|p=33230417|t=2020. SARS-COV2 and P. falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt.|pdf=|usr=}}
{{tp|p=33244341|t=2020. An elevated 8-isoprostaglandin F2 alpha (8-iso-PGF2alpha) in COVID-19 subjects co-infected with malaria.|pdf=|usr=}}
{{tp|p=33198594|t=2020. Immunodominant regions prediction of nucleocapsid protein for SARS-CoV-2 early diagnosis: a bioinformatics and immunoinformatics study.|pdf=|usr=}}
{{tp|p=33131800|t=2020. Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes.|pdf=|usr=}}
{{tp|p=33202215|t=2020. Furin Protease: From SARS CoV-2 to Anthrax, Diabetes, and Hypertension.|pdf=|usr=}}
{{tp|p=33206635|t=2020. Stability of SARS-CoV-2 phylogenies.|pdf=|usr=}}
{{tp|p=33253226|t=2020. SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia.|pdf=|usr=}}
{{tp|p=33232382|t=2020. Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study.|pdf=|usr=}}
{{tp|p=33211781|t=2020. Antibody profiling and prevalence in US patients during the SARS-CoV2 pandemic.|pdf=|usr=}}
{{tp|p=33201914|t=2020. Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics of COVID-19 patients in Hanoi, Vietnam.|pdf=|usr=}}
{{tp|p=33035234|t=2020. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019.|pdf=|usr=}}
{{tp|p=33237441|t=2020. Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody.|pdf=|usr=}}
{{tp|p=33219837|t=2020. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.|pdf=|usr=}}
{{tp|p=33239683|t=2020. Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19.|pdf=|usr=}}
{{tp|p=33199778|t=2020. Similarities and differences between the 'cytokine storms' in acute dengue and COVID-19.|pdf=|usr=}}
{{tp|p=33060566|t=2020. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.|pdf=|usr=}}
{{tp|p=33203855|t=2020. A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins.|pdf=|usr=}}
{{tp|p=33251482|t=2020. Acute Kidney Injury in Multisystem Inflammatory Syndrome in Children (MIS-C): a Case Report.|pdf=|usr=}}
{{tp|p=33235185|t=2020. Influence of social isolation caused by coronavirus disease 2019 (COVID-19) on the psychological characteristics of hospitalized schizophrenia patients: a case-control study.|pdf=|usr=}}
{{tp|p=33221483|t=2020. The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury.|pdf=|usr=}}
{{tp|p=33214057|t=2020. A Potential Role of Interleukin 10 in COVID-19 Pathogenesis.|pdf=|usr=}}
{{tp|p=33207583|t=2020. Antibody Responses to SARS-CoV-2 Antigens in Humans and Animals.|pdf=|usr=}}
{{tp|p=33198287|t=2020. SARS-CoV-2 Proteins Induce IFNG in Th1 Lymphocytes Generated from CD4+ Cells from Healthy, Unexposed Polish Donors.|pdf=|usr=}}
{{tp|p=33232769|t=2020. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.|pdf=|usr=}}
{{tp|p=33210477|t=2020. Evolutionary study of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an emerging coronavirus: Phylogenetic analysis and literature review.|pdf=|usr=}}
{{tp|p=33225958|t=2020. Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33235813|t=2020. Temporal signal and the phylodynamic threshold of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33227343|t=2020. Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a.|pdf=|usr=}}
{{tp|p=33114742|t=2020. Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization.|pdf=|usr=}}
{{tp|p=33207802|t=2020. Recombination and Positive Selection Differentially Shaped the Diversity of Betacoronavirus Subgenera.|pdf=|usr=}}
{{tp|p=33184176|t=2020. The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses.|pdf=|usr=}}
{{tp|p=33184173|t=2020. Analysis of genomic distributions of SARS-CoV-2 reveals a dominant strain type with strong allelic associations.|pdf=|usr=}}
{{tp|p=33231324|t=2020. Prefusion spike protein stabilization through computational mutagenesis.|pdf=|usr=}}
{{tp|p=33174706|t=2020. Les strategies subversives utilisees par SARS-CoV-2 pour supprimer les defenses de l'hote.|pdf=|usr=}}
{{tp|p=33174705|t=2020. Covid-19: que sait-on de la reponse immune humorale au virus SARS-CoV-2 ?|pdf=|usr=}}
{{tp|p=33205496|t=2020. Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment.|pdf=|usr=}}
{{tp|p=33197261|t=2020. Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist.|pdf=|usr=}}
{{tp|p=33205718|t=2020. Multisystem inflammatory syndrome in adult COVID-19 patients.|pdf=|usr=}}
{{tp|p=33208380|t=2020. The known unknowns of T cell immunity to COVID-19.|pdf=|usr=}}
{{tp|p=33184193|t=2020. Enhancing host cell infection by SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33184236|t=2020. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo.|pdf=|usr=}}
{{tp|p=33207070|t=2020. Global SNP analysis of 11,183 SARS-CoV-2 strains reveals high genetic diversity.|pdf=|usr=}}
{{tp|p=33215583|t=2020. [Multisystem inflammatory syndrome in children after SARS-CoV-2 infection].|pdf=|usr=}}
{{tp|p=33202195|t=2020. Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-19.|pdf=|usr=}}
{{tp|p=33198855|t=2020. [Analysis of pathogenesis, syndrome differentiation and treatment of asymptomatic infectors of coronavirus disease 2019 based on the theory of "pathogen hiding in the pleurodiaphragmatic interspace"].|pdf=|usr=}}